EC
ANGO icon

EntryPoint Capital’s AngioDynamics ANGO Stock Holding History

EntryPoint Capital’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,640
Closed -$88.6K – 635
2024
Q2 		$88.6K Buy
14,640
+4,689
+47% +$28.9K 0.04% 869
2024
Q1 		$58.4K Sell
9,951
-1,405
-12% -$8.35K 0.05% 684
2023
Q4 		$89K Buy
+11,356
New +$78.8K 0.09% 438

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EntryPoint Capital's ANGO Position: Q3 2024 in Review

EntryPoint Capital sold out of AngioDynamics (ANGO) in Q3 2024, closing a stake of 14,640 shares — an estimated $88.6K sold.

EntryPoint Capital first reported a position in ANGO in Q4 2023 and held it in 3 quarters. The position peaked at $89K in Q4 2023. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2024.

  • EntryPoint Capital reported no remaining AngioDynamics position as of Q3 2024 after selling out during the quarter.
  • EntryPoint Capital sold 14,640 AngioDynamics shares in Q3 2024, an estimated $88.6K.
  • EntryPoint Capital first reported a position in AngioDynamics in Q4 2023 and held it in 3 quarters.
  • EntryPoint Capital's AngioDynamics position peaked at $89K in Q4 2023.
  • 138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2024.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.